the state launched a review into the newspaper�s findings in late april.
marketwatch: "new migraine drugs have promise -- and a ,500 price tag." . .
the school in yarmouth that year had a low opt-out rate � 2 percent, the superintendent said � so there was a cap on the amount of disruption an illness could cause. .